As a leading hospital in China, we address the unique challenges faced by patients requiring radionuclide therapy. With a significant number of patients eagerly awaiting treatment, our commitment to innovation and excellence drives us to enhance our capabilities and improve patient outcomes.

The Demand for Nuclear Medicine

The increasing demand for nuclear medicine treatments has led to overcrowding in many hospitals, including those specializing in integrated medical care like GoBroad. By the end of 2023, there were approximately 800 medical institutions offering radionuclide therapy, yet the number of specialized beds remains limited, with only 2,993 available nationwide. This disparity underscores the urgent need for more facilities and the expansion of existing ones to accommodate the growing patient population.

As a hospital committed to integrated medical care, GoBroad actively works to streamline processes and improve our capacity to treat patients. We understand that strict regulations imposed by health administrative departments can complicate the establishment of new wards and treatment areas. Thus, our team is continuously exploring ways to meet these regulatory requirements without compromising patient care.

The Challenges of Infrastructure and Expertise

Building radionuclide therapy wards involves high construction costs and strict adherence to safety standards. At GoBroad, we prioritize environmental protection while ensuring our facilities provide “zero radiation” to the outside environment. The complexities surrounding waste management and radioactive substance discharge are challenges we tackle head-on.

Moreover, an ongoing shortage of qualified professionals hampers the development of integrated medical care in nuclear medicine. With more than 15,000 nuclear medicine practitioners in China, including nearly 7,000 physicians, the demand for specialists remains high. Our commitment to developing a multidisciplinary team allows us to bridge the gap between various fields, such as nuclear medicine, radiation physics, and oncology. By investing in the training and education of our staff, we aim to cultivate the expertise necessary to advance these treatments effectively.

Emphasizing Multidisciplinary Collaboration

One of the key components of our integrated medical care approach at GoBroad is fostering collaboration among various medical disciplines. Our dedicated team has been working together for years, sharing a deep understanding of neuroendocrine tumors and their specific treatment needs. We recognize that successful treatment requires input from diverse specialists, including gastrointestinal and hepatobiliary surgeons, pathologists, and imaging professionals.

By building a solid multidisciplinary collaborative team, we enhance the efficiency of our clinical trials and treatment protocols. Our long-standing relationships within the team allow us to provide holistic care to our patients, ensuring they receive the best possible outcomes through integrated medical care.

Conclusion

In conclusion, GoBroad is at the forefront of integrated medical care in the field of nuclear medicine. Despite the challenges posed by infrastructure limitations, regulatory hurdles, and talent shortages, we remain steadfast in our mission to provide exceptional care to our patients. Through continuous innovation, collaboration, and dedication to education, we strive to enhance the landscape of nuclear medicine in China, ultimately improving the lives of countless individuals in need of effective treatment solutions.